Put New Aimovig for Migraine Prophylaxis Into Perspective

August 2018

You'll hear buzz about Aimovig (AIM-oh-vig, erenumab), a new biologic to PREVENT migraine in adults.

It blocks receptors for calcitonin gene-related peptide (CGRP)...a vasodilator and pain sensitizer that spikes during migraine attacks.

Expect other "CGRP antagonists" to be approved within a few months.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote